Portfolio company
IFM Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops small molecule medicines targeting the innate immune system to treat patients with inflammatory diseases and cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Forward Therapeutics
The company develops oral small-molecule medicines for patients with chronic immunological and inflammatory disorders.
NodThera
The company develops oral small molecule inhibitors for inflammatory diseases to treat patients with cardiovascular, neurological and metabolic conditions.
Sitryx Therapeutics
The company develops oral small molecule therapies to treat patients with autoimmune and inflammatory diseases by regulating immune cell metabolism.
Promakhos
This company develops oral small-molecule immunotherapies that restore immune system function to treat patients with chronic inflammatory diseases.
Evommune
This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.
Promakhos Therapeutics
This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.
Nuvig
Nuvig Therapeutics develops immunomodulatory medicines to treat patients with chronic inflammatory and autoimmune diseases.
OMass Therapeutics
This company develops small molecule therapeutics for patients with immunological and rare diseases using a proprietary native mass spectrometry platform.